齊藤聡 日本の医学者
斎藤, 穎, 1942-
VIAF ID: 257889786 (Personal)
Permalink: http://viaf.org/viaf/257889786
Preferred Forms
-
100 1 _ ‡a 斎藤, 穎, ‡d 1942-
-
100 0 _ ‡a 齊藤聡 ‡c 日本の医学者
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Intravascular ultrasound manyuaru |
![]() |
IVUS manyuaru : Kekkannai chōonpahō |
![]() |
IVUSマニュアル : 血管内超音波法 |
![]() |
A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. |
![]() |
Long-term outcome of entecavir treatment of nucleos |
![]() |
Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C. |
![]() |
Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine. |
![]() |
Multicenter, multivendor phantom study to validate proton density fat fraction and T2* values calculated using vendor-provided 6-point DIXON methods. |
![]() |
New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle. |
![]() |
New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma |
![]() |
New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease |
![]() |
New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan |
![]() |
No-touch ablation in HCC has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection |
![]() |
Origin of neovascular structure in an early stage of hepatocellular carcinoma: study of alpha-smooth muscle actin immunohistochemistry in serial thin sections of surgically resected cancer |
![]() |
Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis |
![]() |
A Pilot Study of Thymosin .ALPHA.1 Therapy for Chronic Hepatitis B Patients |
![]() |
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal Liver |
![]() |
Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. |
![]() |
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment |
![]() |
Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses |
![]() |
Potential of ultra-highly sensitive immunoassays for hepatitis B surface and core-related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance |
![]() |
Precore wild-type hepatitis B virus with G1896 in the resolution of persistent hepatitis B virus infection. |
![]() |
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts |
![]() |
Prediction of treatment efficacy and telaprevir-resistant variants after triple therapy in patients infected with hepatitis C virus genotype 1. |
![]() |
Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease |
![]() |
Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis |
![]() |
Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL. |
![]() |
Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b. |
![]() |
Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov model. |
![]() |
Previous chemoembolization response after transcatheter arterial chemoembolization |
![]() |
Primary liver carcinoma with sarcomatous changes: Analysis of 10 cases |
![]() |
Rapid and high sensitive detection of Y93H amino acid substitution in HCV NS5A region using the PCR-Invader assay |
![]() |
Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathy |
![]() |
Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial |
![]() |
Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan |
![]() |
Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. |
![]() |
Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B |
![]() |
Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan. |
![]() |
Role of NS5A-L31/Y93 Double Wild-type in Failure of Glecaprevir/Pibrentasvir Double Therapy in Two Patients with a History of Direct-acting Antiviral Agent Failure: An Ultra-deep Sequencing Analysis |
![]() |
Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b. |
![]() |
Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up. |
![]() |
Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B. |
![]() |
SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology |
![]() |
Shindenzu shindan kijun 110 |
![]() |
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis. |
![]() |
Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C. |
![]() |
Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation. |
![]() |
Sustained negativity for HCV-RNA over 24 or more months by long-term interferon therapy correlates with eradication of HCV in patients with hepatitis C virus genotype 1b and high viral load |
![]() |
Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection. |
![]() |
Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir |
![]() |
TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease |
![]() |
Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis |
![]() |
[Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure]. |
![]() |
Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy |
![]() |
Undifferentiated carcinoma of the liver demonstrated by contrast-enhanced ultrasonography |
![]() |
Usefulness of the serum KL-6 assay in patients with hepatitis C virus |
![]() |
これだけは知っておきたいやさしい心電図の見方 : おもな心疾患と治療のポイント |
![]() |
心筋梗塞 Myocardial infarction |
![]() |
心電図診断基準110 |
![]() |
冠循環への新しいアプローチ : Beyond angiography |
![]() |